nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—SULT1E1—Estrogen metabolism—COMT—bipolar disorder	0.0948	0.123	CbGpPWpGaD
Cyclizine—SULT1E1—Metapathway biotransformation—AKR1C4—bipolar disorder	0.0428	0.0553	CbGpPWpGaD
Cyclizine—SULT1E1—Phase II conjugation—COMT—bipolar disorder	0.0266	0.0345	CbGpPWpGaD
Cyclizine—Ifenprodil—GRIN1—bipolar disorder	0.0261	0.115	CrCbGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD5—bipolar disorder	0.025	0.0324	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD5—bipolar disorder	0.021	0.0272	CbGpPWpGaD
Cyclizine—Ifenprodil—GRIN2B—bipolar disorder	0.0161	0.0706	CrCbGaD
Cyclizine—SULT1E1—Biological oxidations—COMT—bipolar disorder	0.0156	0.0202	CbGpPWpGaD
Cyclizine—SULT1E1—Biological oxidations—MAOA—bipolar disorder	0.0155	0.02	CbGpPWpGaD
Cyclizine—SULT1E1—Metapathway biotransformation—COMT—bipolar disorder	0.0154	0.0199	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—HTR1A—bipolar disorder	0.0146	0.0189	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—HTR2C—bipolar disorder	0.0141	0.0182	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD1—bipolar disorder	0.0141	0.0182	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD3—bipolar disorder	0.0137	0.0177	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—IMPA2—bipolar disorder	0.0133	0.0173	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD4—bipolar disorder	0.0133	0.0172	CbGpPWpGaD
Cyclizine—HRH1—Monoamine GPCRs—DRD2—bipolar disorder	0.0123	0.016	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0123	0.0159	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0121	0.0157	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0118	0.0153	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0118	0.0153	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0115	0.0149	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0111	0.0144	CbGpPWpGaD
Cyclizine—HRH1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0104	0.0134	CbGpPWpGaD
Cyclizine—Orphenadrine—GRIN1—bipolar disorder	0.0103	0.0453	CrCbGaD
Cyclizine—SULT1E1—Biological oxidations—POMC—bipolar disorder	0.0101	0.013	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—GATA3—bipolar disorder	0.00951	0.0123	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—IMPA1—bipolar disorder	0.009	0.0117	CbGpPWpGaD
Cyclizine—Reboxetine—HTR2C—bipolar disorder	0.00877	0.0386	CrCbGaD
Cyclizine—HRH1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00865	0.0112	CbGpPWpGaD
Cyclizine—Bepridil—CACNA1C—bipolar disorder	0.00818	0.0359	CrCbGaD
Cyclizine—Diphenylpyraline—SLC6A3—bipolar disorder	0.00802	0.0353	CrCbGaD
Cyclizine—SULT1E1—Metabolism—NDUFV2—bipolar disorder	0.00765	0.00991	CbGpPWpGaD
Cyclizine—Cinnarizine—CACNA1C—bipolar disorder	0.00744	0.0327	CrCbGaD
Cyclizine—SULT1E1—Metabolism—AKR1C4—bipolar disorder	0.00741	0.0096	CbGpPWpGaD
Cyclizine—Loxapine—DRD5—bipolar disorder	0.00741	0.0326	CrCbGaD
Cyclizine—Reboxetine—SLC6A4—bipolar disorder	0.00727	0.032	CrCbGaD
Cyclizine—HRH1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00727	0.00941	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00683	0.00884	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NR1D1—bipolar disorder	0.00666	0.00862	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NCAN—bipolar disorder	0.00637	0.00825	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—SLC5A3—bipolar disorder	0.00624	0.00808	CbGpPWpGaD
Cyclizine—Benzatropine—SLC6A3—bipolar disorder	0.00615	0.027	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00611	0.00791	CbGpPWpGaD
Cyclizine—Metixene—HTR2C—bipolar disorder	0.00601	0.0264	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00483	0.00625	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00473	0.00613	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00461	0.00597	CbGpPWpGaD
Cyclizine—Cyproheptadine—HTR2C—bipolar disorder	0.00456	0.02	CrCbGaD
Cyclizine—Modafinil—SLC6A3—bipolar disorder	0.00455	0.02	CrCbGaD
Cyclizine—Prochlorperazine—DRD3—bipolar disorder	0.00455	0.02	CrCbGaD
Cyclizine—SULT1E1—Metabolism—CLOCK—bipolar disorder	0.00451	0.00584	CbGpPWpGaD
Cyclizine—Cyproheptadine—HTR1A—bipolar disorder	0.00442	0.0195	CrCbGaD
Cyclizine—HRH1—G alpha (q) signalling events—TACR1—bipolar disorder	0.0044	0.0057	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CACNB2—bipolar disorder	0.0044	0.00569	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—TSHB—bipolar disorder	0.0044	0.00569	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—TPH2—bipolar disorder	0.0044	0.00569	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—DPYD—bipolar disorder	0.00433	0.0056	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00423	0.00548	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00414	0.00536	CbGpPWpGaD
Cyclizine—Mianserin—DRD3—bipolar disorder	0.00411	0.0181	CrCbGaD
Cyclizine—SULT1E1—Metabolism—CACNA1C—bipolar disorder	0.00402	0.00521	CbGpPWpGaD
Cyclizine—Benzphetamine—SLC6A3—bipolar disorder	0.00395	0.0174	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00394	0.0051	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3C2A—bipolar disorder	0.00392	0.00507	CbGpPWpGaD
Cyclizine—Atomoxetine—SLC6A3—bipolar disorder	0.00392	0.0172	CrCbGaD
Cyclizine—Mianserin—SLC6A3—bipolar disorder	0.00383	0.0168	CrCbGaD
Cyclizine—Prochlorperazine—HTR2C—bipolar disorder	0.00382	0.0168	CrCbGaD
Cyclizine—Loxapine—DRD4—bipolar disorder	0.00379	0.0167	CrCbGaD
Cyclizine—Cyproheptadine—DRD2—bipolar disorder	0.00376	0.0165	CrCbGaD
Cyclizine—HRH1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00359	0.00464	CbGpPWpGaD
Cyclizine—Atomoxetine—HTR2C—bipolar disorder	0.00353	0.0155	CrCbGaD
Cyclizine—HRH1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00352	0.00455	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—SNAP25—bipolar disorder	0.00351	0.00455	CbGpPWpGaD
Cyclizine—Mianserin—HTR2C—bipolar disorder	0.00345	0.0152	CrCbGaD
Cyclizine—Mianserin—HTR1A—bipolar disorder	0.00335	0.0147	CrCbGaD
Cyclizine—Cinnarizine—DRD2—bipolar disorder	0.00328	0.0144	CrCbGaD
Cyclizine—Loxapine—DRD3—bipolar disorder	0.00327	0.0144	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00321	0.00415	CbGpPWpGaD
Cyclizine—Loxapine—DRD1—bipolar disorder	0.00321	0.0141	CrCbGaD
Cyclizine—Clozapine—DRD4—bipolar disorder	0.00318	0.014	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—DRD5—bipolar disorder	0.00315	0.00408	CbGpPWpGaD
Cyclizine—Prochlorperazine—DRD2—bipolar disorder	0.00315	0.0138	CrCbGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00315	0.00407	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00314	0.00406	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ADCY2—bipolar disorder	0.00311	0.00403	CbGpPWpGaD
Cyclizine—Loxapine—SLC6A3—bipolar disorder	0.00304	0.0134	CrCbGaD
Cyclizine—Atomoxetine—SLC6A4—bipolar disorder	0.00293	0.0129	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00292	0.00377	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00292	0.00377	CbGpPWpGaD
Cyclizine—Cyproheptadine—HTR2A—bipolar disorder	0.0029	0.0128	CrCbGaD
Cyclizine—Mianserin—SLC6A4—bipolar disorder	0.00286	0.0126	CrCbGaD
Cyclizine—Mianserin—DRD2—bipolar disorder	0.00285	0.0125	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00282	0.00365	CbGpPWpGaD
Cyclizine—Loxapine—HTR2C—bipolar disorder	0.00274	0.0121	CrCbGaD
Cyclizine—Clozapine—DRD3—bipolar disorder	0.00274	0.0121	CrCbGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00272	0.00352	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00272	0.00352	CbGpPWpGaD
Cyclizine—Clozapine—DRD1—bipolar disorder	0.00269	0.0118	CrCbGaD
Cyclizine—Loxapine—HTR1A—bipolar disorder	0.00266	0.0117	CrCbGaD
Cyclizine—SULT1E1—Metabolism—COMT—bipolar disorder	0.00266	0.00345	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—MAOA—bipolar disorder	0.00264	0.00342	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00263	0.00341	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00256	0.00331	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00252	0.00326	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00241	0.00312	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00238	0.00308	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00238	0.00308	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00233	0.00302	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00233	0.00302	CbGpPWpGaD
Cyclizine—Clozapine—HTR2C—bipolar disorder	0.0023	0.0101	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—ADM—bipolar disorder	0.00228	0.00295	CbGpPWpGaD
Cyclizine—Loxapine—SLC6A4—bipolar disorder	0.00227	0.01	CrCbGaD
Cyclizine—Loxapine—DRD2—bipolar disorder	0.00226	0.00994	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00226	0.00292	CbGpPWpGaD
Cyclizine—Atomoxetine—HTR2A—bipolar disorder	0.00225	0.00989	CrCbGaD
Cyclizine—Clozapine—HTR1A—bipolar disorder	0.00224	0.00983	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—TSHB—bipolar disorder	0.00222	0.00287	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—TACR1—bipolar disorder	0.00222	0.00287	CbGpPWpGaD
Cyclizine—Mianserin—HTR2A—bipolar disorder	0.0022	0.00967	CrCbGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00219	0.00284	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00216	0.00279	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—MTHFR—bipolar disorder	0.00215	0.00279	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00204	0.00265	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00204	0.00264	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DGKH—bipolar disorder	0.00195	0.00252	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00193	0.0025	CbGpPWpGaD
Cyclizine—Clozapine—DRD2—bipolar disorder	0.0019	0.00835	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—HTR1A—bipolar disorder	0.00184	0.00238	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—TAC1—bipolar disorder	0.00181	0.00234	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00179	0.00232	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD5—bipolar disorder	0.00178	0.0023	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HTR2C—bipolar disorder	0.00177	0.0023	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—DRD1—bipolar disorder	0.00177	0.0023	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DGKH—bipolar disorder	0.00177	0.00229	CbGpPWpGaD
Cyclizine—Loxapine—HTR2A—bipolar disorder	0.00175	0.00768	CrCbGaD
Cyclizine—HRH1—GPCR downstream signaling—RGS4—bipolar disorder	0.00175	0.00226	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—POMC—bipolar disorder	0.00172	0.00223	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—DRD3—bipolar disorder	0.00172	0.00222	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—INS—bipolar disorder	0.00171	0.00222	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—COMT—bipolar disorder	0.00168	0.00217	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00167	0.00216	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—DRD4—bipolar disorder	0.00167	0.00216	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—MAOA—bipolar disorder	0.00167	0.00216	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	0.00166	0.00214	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD5—bipolar disorder	0.00162	0.00209	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.00161	0.00209	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RGS4—bipolar disorder	0.00159	0.00205	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—DRD2—bipolar disorder	0.00155	0.00201	CbGpPWpGaD
Cyclizine—Clozapine—HTR2A—bipolar disorder	0.00147	0.00645	CrCbGaD
Cyclizine—CYP2C9—Metabolism—IMPA2—bipolar disorder	0.00144	0.00186	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00143	0.00185	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00135	0.00175	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADM—bipolar disorder	0.00129	0.00167	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00125	0.00162	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—TSHB—bipolar disorder	0.00125	0.00162	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—TACR1—bipolar disorder	0.00125	0.00162	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—TRPC3—bipolar disorder	0.00123	0.00159	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADM—bipolar disorder	0.00117	0.00151	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00114	0.00148	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PDE4B—bipolar disorder	0.00114	0.00147	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—TSHB—bipolar disorder	0.00114	0.00147	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—TACR1—bipolar disorder	0.00114	0.00147	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKR1C4—bipolar disorder	0.00113	0.00147	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00109	0.00141	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	0.00109	0.00141	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—POMC—bipolar disorder	0.00109	0.00141	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DGKH—bipolar disorder	0.00104	0.00135	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00104	0.00134	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	0.00102	0.00132	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	0.001	0.0013	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	0.001	0.0013	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	0.000971	0.00126	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.000971	0.00126	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD5—bipolar disorder	0.000955	0.00124	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000949	0.00123	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	0.000943	0.00122	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	0.000943	0.00122	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RGS4—bipolar disorder	0.000937	0.00121	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—TAC1—bipolar disorder	0.000929	0.0012	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD1—bipolar disorder	0.000911	0.00118	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	0.000911	0.00118	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000888	0.00115	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD3—bipolar disorder	0.000882	0.00114	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	0.000878	0.00114	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—POMC—bipolar disorder	0.000869	0.00113	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD4—bipolar disorder	0.000856	0.00111	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.000825	0.00107	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	0.000806	0.00104	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.000799	0.00103	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—DRD2—bipolar disorder	0.000798	0.00103	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TRPC3—bipolar disorder	0.000724	0.000937	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000718	0.000929	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.000691	0.000894	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000687	0.000889	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.000673	0.000871	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.000673	0.000871	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.000673	0.000871	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.000673	0.000871	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000615	0.000796	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.000559	0.000723	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.000557	0.000721	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.000549	0.00071	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.000538	0.000696	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.000538	0.000696	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000523	0.000677	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000521	0.000674	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000519	0.000672	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.000506	0.000655	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	0.000491	0.000636	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CLOCK—bipolar disorder	0.000486	0.00063	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	0.000476	0.000616	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	0.000474	0.000614	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TPH2—bipolar disorder	0.000474	0.000614	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TSHB—bipolar disorder	0.000474	0.000614	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CACNB2—bipolar disorder	0.000474	0.000614	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD2—bipolar disorder	0.000471	0.00061	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—DPYD—bipolar disorder	0.000466	0.000604	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—POMC—bipolar disorder	0.000446	0.000578	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CACNA1C—bipolar disorder	0.000434	0.000561	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	0.000427	0.000552	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	0.000422	0.000547	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000417	0.00054	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—S100B—bipolar disorder	0.000415	0.000537	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SNAP25—bipolar disorder	0.000379	0.000491	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NRG1—bipolar disorder	0.000366	0.000474	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADCY2—bipolar disorder	0.000335	0.000434	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	0.00033	0.000427	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—COMT—bipolar disorder	0.000287	0.000372	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MAOA—bipolar disorder	0.000285	0.000369	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	0.000266	0.000344	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—POMC—bipolar disorder	0.000264	0.000341	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INS—bipolar disorder	0.000262	0.000339	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—bipolar disorder	0.000232	0.0003	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—POMC—bipolar disorder	0.000186	0.00024	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—INS—bipolar disorder	0.000185	0.000239	CbGpPWpGaD
